Literature DB >> 20431479

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Elisabetta Kuhn1, Alan Meeker, Tian-Li Wang, Ann Smith Sehdev, Robert J Kurman, Ie-Ming Shih.   

Abstract

Short telomeres are one of the main genetic manifestations in human cancer, as they have been shown to play an important role in inducing chromosomal instability and in contributing to tumor progression. The purpose of this study was to determine if changes in telomere length occur in serous tubal intraepithelial carcinoma (STIC), the putative precursor of "ovarian" high-grade serous carcinoma (HGSC). Twenty-two STICs from 15 patients with concurrent but discrete HGSCs were analyzed for telomere length on formalin-fixed, paraffin-embedded sections by conducting p53 immunofluorescence to assist in identifying STICs and telomere-specific FISH. Telomere length (short, long, or no change) in STICs was compared with HGSCs using normal fallopian tube epithelium and stromal cells as controls. We found that STICs had the shortest telomeres, as 18 (82%) of 22 STICs had short telomeres, whereas only 2 (9%) showed no change and 2 (9%) had long telomeres compared with the normal-looking tubal epithelium. In contrast, among 12 paired HGSCs and STICs, 6 HGSCs showed an increase in telomere length, one showed a decrease in length and 5 did not show any change when compared with their matched STICs, although, such as STICs, the majority of HGSCs had shorter telomeres than the associated normal tubal epithelial cells. These differences in telomere length between normal tubal epithelial cells and STICs, and between STICs and HGSCs were statisticaly significant (P<0.05). In conclusion, the finding of short telomeres, which have been shown to be one of the earliest molecular changes in carcinogenesis, in a vast majority of STICs provides further support to the proposal that STICs are precursors of HGSC and opens new areas of research in elucidating the early events of ovarian high-grade serous carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431479      PMCID: PMC4778420          DOI: 10.1097/PAS.0b013e3181dcede7

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  45 in total

1.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

Review 2.  Human cell senescence as a DNA damage response.

Authors:  T von Zglinicki; G Saretzki; J Ladhoff; F d'Adda di Fagagna; S P Jackson
Journal:  Mech Ageing Dev       Date:  2005-01       Impact factor: 5.432

3.  Telomerase activity in ovarian tumors.

Authors:  J Murakami; N Nagai; K Ohama; H Tahara; T Ide
Journal:  Cancer       Date:  1997-09-15       Impact factor: 6.860

Review 4.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

5.  The relationship between telomere length and telomerase activity in gynecologic cancers.

Authors:  Shi-Jun Wang; Takanori Sakamoto; Shin-ichi Yasuda Si; Ichio Fukasawa; Yoriko Ota; Masatoshi Hayashi; Takeyoshi Okura; Jian-Hua Zheng; Noriyuki Inaba
Journal:  Gynecol Oncol       Date:  2002-01       Impact factor: 5.482

6.  Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.

Authors:  Tomasz Dziaman; Tomasz Huzarski; Daniel Gackowski; Rafal Rozalski; Agnieszka Siomek; Anna Szpila; Jolanta Guz; Jan Lubinski; Ryszard Olinski
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

7.  Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.

Authors:  Kuan-Ting Kuo; Bin Guan; Yuanjian Feng; Tsui-Lien Mao; Xu Chen; Natini Jinawath; Yue Wang; Robert J Kurman; Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

8.  Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma.

Authors:  Donna E Hansel; Alan K Meeker; Jessica Hicks; Angelo M De Marzo; Keith D Lillemoe; Richard Schulick; Ralph H Hruban; Anirban Maitra; Pedram Argani
Journal:  Mod Pathol       Date:  2006-06       Impact factor: 7.842

Review 9.  Telomeres and aging.

Authors:  Geraldine Aubert; Peter M Lansdorp
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

10.  Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention.

Authors:  William J Murdoch; James F Martinchick
Journal:  Exp Biol Med (Maywood)       Date:  2004-06
View more
  46 in total

1.  Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-20       Impact factor: 4.254

2.  Telomere length and mortality following a diagnosis of ovarian cancer.

Authors:  Joanne Kotsopoulos; Jennifer Prescott; Immaculata De Vivo; Isabel Fan; John Mclaughlin; Barry Rosen; Harvey Risch; Ping Sun; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-26       Impact factor: 4.254

3.  Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.

Authors:  Elisabetta Kuhn; Alan K Meeker; Kala Visvanathan; Amy L Gross; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

4.  The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.

Authors:  Elisabetta Kuhn; Robert J Kurman; Robert A Soslow; Guangming Han; Ann Smith Sehdev; Patrick J Morin; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

5.  The forgotten fallopian tube.

Authors:  Johannes Dietl; Jörg Wischhusen
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

Review 6.  Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.

Authors:  Felix Zeppernick; Ivo Meinhold-Heerlein; Ie-Ming Shih
Journal:  J Obstet Gynaecol Res       Date:  2014-10-20       Impact factor: 1.730

7.  Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention.

Authors:  Kelly A Biegler; Amanda K L Anderson; Lari B Wenzel; Kathryn Osann; Edward L Nelson
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-24

8.  Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.

Authors:  Naveena Singh; Asma Faruqi; Friedrich Kommoss; W Glenn McCluggage; Giorgia Trevisan; Janine Senz; Amy Lum; C Blake Gilks; Michael Anglesio
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

9.  New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.

Authors:  Lan G Coffman; Daniela Burgos-Ojeda; Rong Wu; Kathleen Cho; Shoumei Bai; Ronald J Buckanovich
Journal:  Transl Res       Date:  2016-03-30       Impact factor: 7.012

Review 10.  Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Authors:  Mark E Sherman; Ronny I Drapkin; Neil S Horowitz; Christopher P Crum; Sue Friedman; Janice S Kwon; Douglas A Levine; Ie-Ming Shih; Donna Shoupe; Elizabeth M Swisher; Joan Walker; Britton Trabert; Mark H Greene; Goli Samimi; Sarah M Temkin; Lori M Minasian
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.